Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00610415 · ClinicalTrials.gov registry record

Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study

A clinical trial of Head and Neck Cancer and Head and Neck Cancers, sponsored by Stanford University.

Completed
Registry status
40
Enrollment target
1
Study location

NCT00610415: Completed study of Head and Neck Cancer and Head and Neck Cancers, sponsored by Stanford University.

NCT00610415 is a study of Head and Neck Cancer and Head and Neck Cancers that has completed, run by Stanford University. The registered enrollment target is 40 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00610415, a study of Head and Neck Cancer and Head and Neck Cancers, has completed, sponsored by Stanford University.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather adequate tissue for cancer stem cell quantification.

Interventions

  • PROCEDURE tumor biopsy

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2007-12
Stanford University

1,744 total trials

What the finished NCT00610415 record still lists

NCT00610415 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which tumor biopsy is the first listed.

NCT00610415 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00610415 about?

NCT00610415 is a clinical study titled "Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study". To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather adequate tissue for cancer stem cell quantification.

What is the current status of trial NCT00610415?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2007-12.

What conditions does trial NCT00610415 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Head and Neck Cancers.

What interventions are being tested in trial NCT00610415?

The interventions under investigation include: tumor biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT00610415?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00610415 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00610415's enrollment target sits among peer trials

40 142nd of 250 higher than 99 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00610415, the US trial registry maintained by the National Library of Medicine. NCT00610415 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.